Impact of Abuse-Deterrent OxyContin on Prescription Opioid Utilization in the United States

被引：0
|
作者：
Hwang, Catherine S. [1 ,2 ]
Chang, Hsien-Yen [1 ,3 ]
Alexander, G. Caleb [1 ,4 ,5 ]
机构：
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Drug Safety & Effectiveness, Baltimore, MD USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[5] Johns Hopkins Med, Div Gen Internal Med, Baltimore, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
685
引用
收藏
页码：367 / 367
页数：1
相关论文
共 50 条
  • [1] Impact of abuse-deterrent OxyContin on prescription opioid utilization
    Hwang, Catherine S.
    Chang, Hsien-Yen
    Alexander, G. Caleb
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 (02) : 197 - 204
  • [2] Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States Lessons Learned From OxyContin
    Cicero, Theodore J.
    Ellis, Matthew S.
    [J]. JAMA PSYCHIATRY, 2015, 72 (05) : 424 - 429
  • [3] IMPACT OF INTRODUCTION OF ABUSE-DETERRENT OXYCONTIN ON OPIOID OVERDOSE RATES
    Larochelle, Marc
    Zhang, Fang
    Ross-Degnan, Dennis
    Wharam, James F.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2014, 29 : S120 - S120
  • [4] Abuse-Deterrent OxyContin And Hepatitis C
    Bigal, Marcelo E.
    [J]. HEALTH AFFAIRS, 2019, 38 (04)
  • [5] Effect of Abuse-Deterrent Formulation of OxyContin
    Cicero, Theodore J.
    Ellis, Matthew S.
    Surratt, Hilary L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02): : 187 - 189
  • [6] Challenges in the development of prescription opioid abuse-deterrent formulations
    Katz, Nathaniel P.
    Adams, Edgar H.
    Chilcoat, Howard
    Colucci, Robert D.
    Comer, Sandra D.
    Goliber, Philip
    Grudzinskas, Charles
    Jasinski, Donald
    Lande, Stephen D.
    Passik, Steven D.
    Schnoll, Sidney H.
    Sellers, Edward
    Travers, Debra
    Weiss, Roger
    [J]. CLINICAL JOURNAL OF PAIN, 2007, 23 (08): : 648 - 660
  • [7] The Effect of an Abuse-Deterrent Opioid Formulation (OxyContin) on Opioid Abuse-Related Outcomes in the Postmarketing Setting
    Coplan, P. M.
    Chilcoat, H. D.
    Butler, S. F.
    Sellers, E. M.
    Kadakia, A.
    Harikrishnan, V.
    Haddox, J. D.
    Dart, R. C.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (03) : 275 - 286
  • [8] Abuse-deterrent OxyContin: shift in abuse drug of choice
    [J]. Reactions Weekly, 2012, 1411 (1) : 2 - 2
  • [9] Use of prescription opioids with abuse-deterrent technology to address opioid abuse
    Michna, Edward
    Kirson, Noam Y.
    Shei, Amie
    Birnbaum, Howard G.
    Ben-Joseph, Rami
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (08) : 1589 - 1598
  • [10] Evaluating dynamic impacts of abuse-deterrent prescription opioid formulations
    Humphreys, Keith
    [J]. ADDICTION, 2019, 114 (03) : 400 - 401
12345